Recombinant Pirital virus RNA-directed RNA polymerase L (L), partial

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized preparation.
Lead Time
Delivery times vary depending on the purchase method and location. Please consult your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs. Dry ice shipping requires advance notification and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to consolidate the contents. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our standard glycerol concentration is 50%, provided as a guideline.
Shelf Life
Shelf life depends on several factors: storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The tag type is determined during production. Please specify your desired tag type for prioritized development.
Synonyms
LRNA-directed RNA polymerase L; Protein L; EC 2.7.7.48; EC 3.1.-.-; Large structural protein; Replicase; Transcriptase
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Protein Length
Partial
Purity
>85% (SDS-PAGE)
Species
Pirital mammarenavirus (isolate Rat/Venezuela/VAV-488/1995) (PIRV)
Target Names
L
Uniprot No.

Target Background

Function
This RNA-dependent RNA polymerase is responsible for replicating and transcribing the viral RNA genome. During transcription, it synthesizes four subgenomic RNAs and ensures their capping via a cap-snatching mechanism, utilizing cellular capped pre-mRNAs as primers. The 3' ends of subgenomic mRNA molecules are heterogeneous and lack polyadenylation. The replicase function directs the synthesis of antigenomic and genomic RNA, which are encapsidated and uncapped. The use of the same enzyme for transcription and replication necessitates precise coordination, potentially regulated by proteins N and Z in a dose-dependent manner.
Database Links

KEGG: vg:2943174

Protein Families
Arenaviridae RNA polymerase family
Subcellular Location
Virion. Host cytoplasm.

Q&A

What are the structural and functional characteristics of arenavirus RNA polymerases?

Arenavirus RNA polymerases (L proteins) are large multifunctional proteins encoded by the L segment of the bisegmented negative-strand RNA genome. These enzymes share structural features with other negative-strand RNA virus polymerases but possess unique characteristics. The polymerase domain contains conserved motifs necessary for nucleotide incorporation, while additional domains provide cap-snatching endonuclease activity and other functions. Functionally, these polymerases replicate the viral genome and transcribe viral mRNAs, with their error-prone nature contributing to viral evolution and adaptation .

How does activation of arenavirus polymerases occur?

Arenavirus L proteins are activated through direct interaction with the 5' viral RNA sequences, in coordination with their respective 3' promoter regions. This RNA-guided activation mechanism is critical for promoter-specific polymerase regulation. The highly conserved sequences in both the 3' and 5' termini mediate panhandle duplex separation and 5' structure formation for activation of the polymerase. This interaction is essential for both genomic and antigenomic RNA synthesis and is dependent upon the prime-and-realign mechanism characteristic of arenavirus genome replication .

What protein-protein interactions regulate arenavirus polymerase activity?

Arenavirus polymerases engage in multiple protein-protein interactions that modulate their activity. The L protein typically functions in complex with the viral nucleoprotein (NP), which is essential for replication complex formation. Additionally, arenavirus polymerases exist in multiple forms, including as a mature protein and as a precursor protein with the viral protease (similar to the 3CD-like precursor in lagoviruses). These different forms may possess distinct activities. In some related RNA viruses, RdRps can form homodimers and higher-order structures that demonstrate cooperative enzymatic activity, enhancing replication efficiency .

What expression systems are most effective for producing active recombinant arenavirus polymerases?

Producing active recombinant arenavirus polymerases requires careful consideration of expression systems. Based on approaches used with related viruses, researchers should consider:

  • Mammalian expression systems with codon optimization for the target cells

  • Baculovirus-insect cell systems that often yield properly folded proteins

  • Cell-free systems supplemented with chaperones for difficult-to-express proteins

Co-expression with the viral nucleoprotein is often essential for optimal activity, as these proteins form functional complexes in vivo. Additionally, expression as a fusion protein with solubility-enhancing tags (MBP, SUMO) can improve yield and stability. Careful optimization of induction conditions, temperature, and buffer composition is critical for maintaining enzymatic activity through the purification process .

How can researchers establish reliable in vitro assays for arenavirus polymerase activity?

To establish robust in vitro assays for arenavirus polymerase activity, researchers should implement the following methodology:

  • Template preparation: Generate authentic viral RNA templates containing both 5' and 3' terminal sequences, as these are critical for polymerase activation

  • Reaction components: Include purified recombinant L protein, nucleoprotein (NP), appropriate divalent cations (Mg²⁺ or Mn²⁺), NTPs, and RNase inhibitors

  • Activation strategy: Pre-incubate polymerase with the 5' RNA element to ensure proper activation before adding the 3' promoter-containing template

  • Detection methods: Employ techniques such as incorporation of radiolabeled or modified nucleotides, qRT-PCR for product quantification, or gel-based visualization of RNA products

  • Controls: Include reactions with catalytically inactive polymerase mutants and non-specific RNA templates

The assay should be validated by demonstrating template specificity and sensitivity to known polymerase inhibitors .

What strategies enable generation of recombinant arenaviruses expressing foreign genes?

Generating recombinant arenaviruses expressing foreign genes requires overcoming significant technical challenges. Based on successful approaches with the prototype arenavirus LCMV, researchers should consider a trisegmented approach:

  • Design a virus containing one L segment and two modified S segments

  • Replace one viral ORF in each S segment with a gene of interest

  • Maintain the authentic viral terminal sequences required for replication

  • Co-transfect cells with plasmids encoding all three segments along with support plasmids expressing NP and L proteins

  • Screen for rescued viruses and verify segment incorporation

This approach has proven successful for LCMV, where the physical separation of glycoprotein and nucleoprotein genes into different S segments creates a selective pressure to maintain all three segments. The resulting recombinant viruses maintain genetic stability while allowing expression of two foreign genes .

How can RNA-protein interactions within the replication complex be characterized?

Characterizing RNA-protein interactions within arenavirus replication complexes requires multiple complementary approaches:

  • RNA binding assays: Electrophoretic mobility shift assays (EMSA) with purified components to determine direct binding

  • Crosslinking techniques: UV crosslinking followed by immunoprecipitation to capture transient interactions

  • Structural studies: X-ray crystallography or cryo-EM of polymerase-RNA complexes

  • Mutational analysis: Systematic mutagenesis of RNA elements and protein domains to map interaction sites

  • Functional assays: Minigenome systems to evaluate the impact of mutations on replication in cells

The 5' RNA elements are particularly important for polymerase activation and should be carefully examined using RNA structure probing techniques like SHAPE analysis. These interactions are often sequence-specific and structure-dependent, requiring precise RNA folding for proper function .

What approaches can identify host factors that interact with arenavirus polymerases?

To identify host factors interacting with arenavirus polymerases, researchers should implement a multi-faceted strategy:

  • Affinity purification-mass spectrometry (AP-MS): Express tagged polymerase in relevant cell types and identify co-purifying proteins

  • Proximity labeling: Use BioID or APEX2 fusion proteins to identify proteins in close proximity to the polymerase in living cells

  • Yeast two-hybrid or mammalian two-hybrid screens: Identify direct protein-protein interactions

  • RNA interference screens: Systematically deplete host factors and monitor effects on viral replication

  • Comparative proteomics: Compare protein interactions across different arenavirus polymerases to identify conserved host dependencies

In related RNA viruses, interactions with host factors like nucleolin have been shown to be necessary for efficient replication. Nucleolin interacts with both the polymerase and viral RNA 3' UTR, potentially promoting the formation of replication complexes .

How can polymerase fidelity be measured and potentially manipulated?

Measuring and manipulating polymerase fidelity requires sophisticated approaches:

  • Cell-based fidelity assays:

    • Use reporter viruses carrying genes that can detect mutation frequency

    • Perform deep sequencing of viral populations to quantify mutation rates

    • Monitor viral adaptation to selective pressures

  • Biochemical fidelity assays:

    • Measure incorporation kinetics of correct versus incorrect nucleotides

    • Assess nucleotide discrimination using modified substrates

    • Determine the impact of divalent cation concentration on misincorporation rates

  • Manipulating fidelity:

    • Introduce mutations in conserved motifs predicted to affect nucleotide selection

    • Target residues in the active site that interact with the incoming nucleotide

    • Modify interactions between polymerase domains that undergo conformational changes during catalysis

The error-prone nature of arenavirus polymerases contributes to their evolutionary potential but also creates opportunities for antiviral strategies targeting fidelity mechanisms .

Table 1: Comparative Properties of Arenavirus RNA Polymerases and Related Viral RdRps

PropertyArenavirus (e.g., Pirital virus)Other Negative-Strand RNA VirusesPositive-Strand RNA Viruses
Protein Size~250 kDa200-250 kDa (Orthomyxoviruses)50-100 kDa (Caliciviruses, Picornaviruses)
Cofactor RequirementsViral NP essentialVaries by virus familyOften autonomous activity
RNA Activation Mechanism5' RNA element bindingSimilar 5' RNA-dependent activationOften protein-mediated
Protein FormBoth mature and precursor formsUsually mature form onlyOften as precursor proteins
Subcellular LocalizationCytoplasmic replication complexesNuclear (Orthomyxoviruses) or cytoplasmicMembrane-associated replication complexes
MultimerizationForms functional multimersFamily-dependentOften forms dimers and higher-order structures
Error Rate (mutations/nt/replication)10⁻⁴ to 10⁻⁵10⁻³ to 10⁻⁵10⁻⁴ to 10⁻⁶

How can recombinant arenavirus polymerases be used for antiviral drug screening?

Recombinant arenavirus polymerases offer powerful platforms for antiviral drug screening:

  • Biochemical screening approaches:

    • High-throughput polymerase activity assays using fluorescent or luminescent readouts

    • Fragment-based screening against purified polymerase

    • Structure-guided virtual screening targeting conserved active sites

  • Cell-based screening systems:

    • Replicon systems expressing reporter genes

    • Trisegmented viruses carrying reporter genes for live virus screening

    • Assays monitoring interferon induction as an indirect measure of polymerase activity

Potential targets include the catalytic site, the critical 5' RNA binding pocket, and interfaces between polymerase domains. The high conservation of terminal sequences among arenaviruses suggests that compounds targeting the 5' RNA-polymerase interaction could have broad-spectrum activity against multiple pathogenic arenaviruses .

What challenges exist in translating in vitro findings to therapeutic applications?

Translating in vitro findings on arenavirus polymerases to therapeutic applications faces several challenges:

  • Selectivity barriers:

    • Distinguishing viral from host polymerases

    • Achieving specificity for particular arenavirus species

    • Balancing potency with toxicity profiles

  • Resistance development:

    • High mutation rates facilitate rapid emergence of resistance

    • Need for combination approaches targeting multiple viral components

    • Requirements for high genetic barriers to resistance

  • Technical limitations:

    • Difficulties in establishing authentic cell culture systems

    • Biosafety requirements for work with pathogenic arenaviruses

    • Limited animal models for efficacy testing

Approaches to overcome these challenges include targeting highly conserved regions of the polymerase, developing combination therapies, and focusing on host-virus interactions that are essential for replication .

How might structural biology approaches advance arenavirus polymerase research?

Structural biology approaches offer transformative potential for arenavirus polymerase research:

  • Cryo-electron microscopy:

    • Visualization of polymerase-RNA complexes in different functional states

    • Determination of structures for large, flexible proteins difficult to crystallize

    • Capturing transient intermediates in the catalytic cycle

  • X-ray crystallography:

    • High-resolution structures of polymerase domains with bound ligands

    • Co-crystallization with RNA elements or small molecule inhibitors

    • Structure-guided drug design

  • NMR spectroscopy:

    • Characterization of RNA structure elements that regulate polymerase activity

    • Analysis of protein dynamics during catalysis

    • Screening of fragment libraries for inhibitor development

The conservation of activating RNA elements among segmented negative-sense RNA viruses suggests structural studies could reveal shared mechanisms of regulation amenable to therapeutic intervention .

Table 2: Experimental Systems for Studying Recombinant Arenavirus Polymerases

SystemKey FeaturesApplicationsLimitations
In vitro reconstituted RdRpPurified components, defined conditionsMechanistic studies, drug screeningLacks cellular context
Minigenome systemsPlasmid-based, no infectious virusPromoter analysis, protein interactionsArtificial expression levels
Virus-like particlesNon-infectious, authentic assemblyEntry and packaging studiesLimited replication cycle
Trisegmented recombinant virusesReporter gene expression, complete life cycleIn vivo pathogenesis, vaccine developmentComplex rescue procedure
Replicon systemsSelf-replicating, no virion productionLong-term studies, reduced biosafety concernsCannot study full virus cycle
Reverse geneticsGeneration of defined mutantsStructure-function analysisTechnical complexity

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.